pCCLc-MNDU3-Luciferase-PGK-EGFP-WPRE Citations (6)

Originally described in: Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo.
Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta JA, Fierro FA Stem Cells. 2015 Jun;33(6):1818-28. doi: 10.1002/stem.1976. Epub 2015 May 11. PubMed Journal

---

Articles Citing pCCLc-MNDU3-Luciferase-PGK-EGFP-WPRE

Articles
Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery. Ewe A, Noske S, Karimov M, Aigner A. Pharmaceutics. 2019 Nov 12;11(11). pii: pharmaceutics11110600. doi: 10.3390/pharmaceutics11110600. PubMed
Immuno-suppressive hydrogels enhance allogeneic MSC survival after transplantation in the injured brain. Alvarado-Velez M, Enam SF, Mehta N, Lyon JG, LaPlaca MC, Bellamkonda RV. Biomaterials. 2021 Jan;266:120419. doi: 10.1016/j.biomaterials.2020.120419. Epub 2020 Sep 28. PubMed
HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias. Mshaik R, Simonet J, Georgievski A, Jamal L, Bechoua S, Ballerini P, Bellaye PS, Mlamla Z, Pais de Barros JP, Geissler A, Francin PJ, Girodon F, Garrido C, Quere R. Blood Cancer J. 2021 Mar 18;11(3):61. doi: 10.1038/s41408-021-00450-2. PubMed
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma. Swan SL, Mehta N, Ilich E, Shen SH, Wilkinson DS, Anderson AR, Segura T, Sanchez-Perez L, Sampson JH, Bellamkonda RV. Front Immunol. 2023 Feb 3;14:1085547. doi: 10.3389/fimmu.2023.1085547. eCollection 2023. PubMed
A complex of Wnt/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant properties. Dreyer CA, VanderVorst K, Natwick D, Bell G, Sood P, Hernandez M, Angelastro JM, Collins SR, Carraway KL 3rd. Cancer Lett. 2023 Jul 28;567:216280. doi: 10.1016/j.canlet.2023.216280. Epub 2023 Jun 17. PubMed
Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers. Georgievski A, Bellaye PS, Tournier B, Choubley H, Pais de Barros JP, Herbst M, Beduneau A, Callier P, Collin B, Vegran F, Ballerini P, Garrido C, Quere R. Cell Death Dis. 2024 May 11;15(5):328. doi: 10.1038/s41419-024-06715-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.